Charles D Blanke

Charles D Blanke

UNVERIFIED PROFILE

Are you Charles D Blanke?   Register this Author

Register author
Charles D Blanke

Charles D Blanke

Publications by authors named "Charles D Blanke"

Are you Charles D Blanke?   Register this Author

99Publications

2048Reads

32Profile Views

The Gift of Dying With Control.

Authors:
Charles D Blanke

Pract Radiat Oncol 2019 Nov 13;9(6):387-388. Epub 2019 Sep 13.

Department of Medicine, Division of Medical Oncology, Oregon Health and Sciences University, Portland, Oregon. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2019.09.002DOI Listing
November 2019

In Memoriam: Charles A. Coltman, 1930 to 2018.

J Clin Oncol 2019 May 12;37(13):1037-1040. Epub 2019 Mar 12.

4 Fox Chase Cancer Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.00270DOI Listing
May 2019

A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies.

J Natl Cancer Inst 2018 06;110(6):553-559

Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005117PMC
June 2018

The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population.

JAMA Oncol 2017 Oct;3(10):1345-1351

SWOG Group Chair's Office, Knight Cancer Institute, Oregon Health & Science University, Portland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.0762DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710507PMC
October 2017

Words matter: Restoring respect and dignity when referring to individuals with cancer.

Cancer 2017 07 9;123(13):2390-2391. Epub 2017 Feb 9.

Gynecologic Cancer Therapeutics, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30625DOI Listing
July 2017

Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518.

J Clin Oncol 2017 May 6;35(15):1695-1703. Epub 2017 Apr 6.

James C. Yao and Cesar Moran, MD Anderson Cancer Center, Houston, TX; Katherine A. Guthrie and Shannon McDonough, Fred Hutchinson Cancer Research Center, Seattle, WA; Jonathan R. Strosberg, H. Lee Moffitt Cancer Center, Tampa, FL; Matthew H. Kulke and Jennifer A. Chan, Dana Farber Cancer Institute, Boston, MA; Noelle LoConte, University of Wisconsin, Carbone Cancer Center, Madison, WI; Robert R. McWilliams, Mayo Clinic College of Medicine, Rochester, MN; Edward M. Wolin, University of Kentucky, Lexington, KY; Edward M. Wolin, Montifiore Einstein Cancer Center, New York, NY; Bassam Mattar, Wichita NCORP/Cancer Center of Kansas, Wichita, KS; Helen Chen, NCI Cancer Therapy Evaluation Program, Bethesda, MD; Charles D. Blanke, Oregon Health & Science University, Portland, OR; and Howard S. Hochster, Yale Cancer Center, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.4072DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455764PMC
May 2017

Duration of Adjuvant Therapy for Patients With Gastrointestinal Stromal Tumors: Where Is Goldilocks When We Need Her?

JAMA Oncol 2016 Jun;2(6):721-2

Division of General Surgical Oncology, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.0094DOI Listing
June 2016

American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention.

J Clin Oncol 2016 05 11;34(15):1803-12. Epub 2016 Apr 11.

Howard H. Bailey, University of Wisconsin Carbone Cancer Center, Madison, WI; Linus T. Chuang, Mount Sinai School of Medicine, New York, NY; Nefertiti C. duPont, Gynecologic Surgeons of North Houston, Shenandoah; Cathy Eng and Lewis E. Foxhall, MD Anderson Cancer Center, Houston, TX; Janette K. Merrill and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA; and Charles D. Blanke, Oregon Health and Science University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.2014DOI Listing
May 2016

The Globalization of Cooperative Groups.

Semin Oncol 2015 Oct 10;42(5):693-712. Epub 2015 Jul 10.

Chair, SWOG; Department of Medicine, Division of Hematology and Medical Oncology, Oregon Health & Science University and Knight Cancer Institute, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2015.07.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592942PMC
October 2015

Chemotherapy Near the End of Life: First--and Third and Fourth (Line)--Do No Harm.

JAMA Oncol 2015 Sep;1(6):785-6

Division of Hematology & Medical Oncology, Knight Cancer Institute & Oregon Health and Science University, Portland2Palliative Care Service, Oregon Health & Science University, Portland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.2379DOI Listing
September 2015

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.

J Clin Oncol 2015 Aug 11;33(24):2617-22. Epub 2015 May 11.

Edgar Ben-Josef, University of Pennsylvania, Philadelphia, PA; Katherine A. Guthrie, Fred Hutchinson Cancer Research Center, Seattle, WA; Anthony B. El-Khoueiry, University of Southern California Norris Comprehensive Cancer Center, Los Angeles; Andrew M. Lowy, University of California San Diego Moores Cancer Center, La Jolla, CA; Christopher L. Corless, Oregon Health and Science University Knight Diagnostic Laboratories; Charles R. Thomas Jr and Charles D. Blanke, Oregon Health and Science University Knight Cancer Institute, Portland, OR; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Steven R. Alberts, Mayo Clinic, Rochester, MN; Laura A. Dawson, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada; Kenneth C. Micetich, Loyola University Medical Center, Maywood, IL; Melanie B. Thomas, Medical University of South Carolina, Charleston, SC; and Abby B. Siegel, Columbia University, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.2219DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534524PMC
August 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

Losing "Losing the Battle With Cancer".

JAMA Oncol 2015 Apr;1(1):13-4

Fight Colorectal Cancer, Alexandria, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2014.188DOI Listing
April 2015

Effect of M1a and M1b category in metastatic colorectal cancer.

Oncologist 2014 Jul 4;19(7):720-6. Epub 2014 Jun 4.

Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Division of Medical Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada; Division of Medical Oncology, Knight Cancer Institute and Oregon Health Science University, Portland, Oregon, USA; Breast and Gastrointestinal Cancer Outcomes Unit, Cancer Surveillance & Outcomes, and Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2013-0442DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077443PMC
July 2014

Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.

J Clin Oncol 2014 May 17;32(15):1563-70. Epub 2014 Mar 17.

Christopher L. Corless, Violetta Kolesnikova, Charles D. Blanke, Michael C. Heinrich, Oregon Health and Science University, Portland, OR; Karla V. Ballman, Mayo Clinic, Rochester, MN; Cristina R. Antonescu and Ronald P. DeMatteo, Memorial Sloan-Kettering Cancer Center; Robert G. Maki, Mt Sinai School of Medicine, New York, NY; Peter W.T. Pisters and Shreyaskumar Patel, University of Texas MD Anderson Cancer Center, Houston, TX; Martin E. Blackstein, Mount Sinai Hospital, Toronto, Ontario, Canada; George D. Demetri, Dana-Farber Cancer Institute, Boston, MA; Margaret von Mehren, Fox Chase Cancer Institute, Philadelphia, PA; Martin D. McCarter, University of Colorado School of Medicine, Aurora, CO; and Kouros Owzar, Duke University School of Medicine, Durham, NC.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.51.2046
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.51.2046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026579PMC
May 2014

SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.

Invest New Drugs 2012 Aug 12;30(4):1646-51. Epub 2011 Jul 12.

University of Southern California/Norris Comprehensive Cancer Center, 1441 Eastlake Ave, Suite 3459, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-011-9719-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490705PMC
August 2012

Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysis.

Clin Colorectal Cancer 2011 Jun 22;10(2):97-101. Epub 2011 Apr 22.

British Columbia Cancer Agency and University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2011.03.004DOI Listing
June 2011

Cost effectiveness of tyrosine kinase inhibitor therapy in metastatic gastrointestinal stromal tumors.

J Med Econ 2010 10;13(4):681-90. Epub 2010 Nov 10.

University of British Columbia and British Columbia Cancer Center, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3111/13696998.2010.534670DOI Listing
May 2011

Gastrointestinal stromal tumors: disease and treatment update.

Gastroenterology 2011 May 21;140(5):1372-6.e2. Epub 2011 Mar 21.

Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2011.03.017DOI Listing
May 2011

Metastatic gastrointestinal stromal tumors.

Cancer Chemother Pharmacol 2011 Jan 30;67 Suppl 1:S9-14. Epub 2010 Nov 30.

Centre Hospitalier de l'Université de Montréal, Notre-Dame Hospital, 1560 Sherbrooke Est, Montreal, QC H2L 4M1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1512-9DOI Listing
January 2011

Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336).

Invest New Drugs 2009 Oct 22;27(5):469-75. Epub 2008 Oct 22.

Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 903 Clinical Science Building, MSC 635, Charleston, SC 29425-6350, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-008-9190-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024913PMC
October 2009

Biomarkers in GIST: partly ready for prime-time use.

Authors:
Charles D Blanke

Clin Cancer Res 2009 Sep 8;15(18):5603-5. Epub 2009 Sep 8.

University of British Columbia and the British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-09-1563DOI Listing
September 2009

Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors.

J Clin Oncol 2009 Jul 18;27(19):3141-7. Epub 2009 May 18.

Ludwig Center, Dana-Farber/Harvard Cancer Center, Dana-Farber Cancer Institute, D1212, 44 Binney St, Boston MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.20.4818DOI Listing
July 2009

Successes and challenges in translational research: the development of targeted therapy for gastrointestinal stromal tumours.

Clin Cancer Res 2009 Jun 9;15(12):3908-11. Epub 2009 Jun 9.

University of British Columbia and the British Columbia Cancer Agency, Vancouver, British Colombia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1622DOI Listing
June 2009

Dual-antibody therapy in advanced colorectal cancer: gather ye rosebuds while ye may.

Authors:
Charles D Blanke

J Clin Oncol 2009 Feb 29;27(5):655-8. Epub 2008 Dec 29.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.21.2522DOI Listing
February 2009

Perioperative treatment of gastrointestinal stromal tumors.

Oncology (Williston Park) 2009 Jan;23(1):54-61

Centro de Oncologia Hospital Sírio-Libanês, São Paulo, Brazil.

View Article

Download full-text PDF

Source
January 2009

Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency.

South Med J 2008 May;101(5):543-5

Division of Hematology and Medical Oncology and Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SMJ.0b013e31816bf5ccDOI Listing
May 2008

Perforation and Stage-II Colon Cancer: Is it Always High Risk?

Authors:
Charles D Blanke

Gastrointest Cancer Res 2008 Mar;2(2):103-4

Division of Medical Oncology, University of British Columbia, Vancouver, BC.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630827PMC
March 2008

Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.

Int J Radiat Oncol Biol Phys 2007 Feb 9;67(2):397-404. Epub 2006 Nov 9.

Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.08.062DOI Listing
February 2007

Outcome following surgical therapy for gastrointestinal stromal tumors.

J Gastrointest Surg 2006 Sep-Oct;10(8):1099-105

Department of Surgery, Oregon Health & Science University, Portland, Oregon 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gassur.2006.05.014DOI Listing
December 2006

Gastrointestinal stromal tumors: imatinib and beyond.

Curr Treat Options Oncol 2006 Nov;7(6):427-37

Oregon Health Sciences University Cancer Institute, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s11864-006-0018
Web Search
http://dx.doi.org/10.1007/s11864-006-0018-5DOI Listing
November 2006

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

J Clin Oncol 2006 Oct 5;24(29):4764-74. Epub 2006 Sep 5.

Division of Hematology/Oncology, Department of Pathology, Oregon Health & Science University Cancer Institute, Oregon Health & Science University, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.06.2265DOI Listing
October 2006

Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.

Oncologist 2006 Jan;11(1):9-20

Sarcoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.11-1-9DOI Listing
January 2006

Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma.

Clin Colorectal Cancer 2005 Nov;5(4):292-4

Cancer and Leukemia Group B, Department of Clinical Medicine, University of California-San Francisco, 600 Divisadero Box 1770, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/ccc.2005.n.043DOI Listing
November 2005

Whither irinotecan?

Authors:
Charles D Blanke

J Clin Oncol 2005 Aug 6;23(22):4811-4. Epub 2005 Jun 6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.01.914DOI Listing
August 2005

Gefitinib in colorectal cancer: if wishes were horses.

Authors:
Charles D Blanke

J Clin Oncol 2005 Aug;23(24):5446-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.904DOI Listing
August 2005

Gastrointestinal stromal tumors and the evolution of targeted therapy.

Clin Adv Hematol Oncol 2005 Aug;3(8):647-57

Oregon Health and Science University Cancer Institute, Portland, Oregon 97239, USA.

View Article

Download full-text PDF

Source
August 2005

State-of-the art therapy for gastrointestinal stromal tumors.

Cancer Invest 2005 ;23(3):274-80

Department of Medicine, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon 97201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1081/cnv-200055972DOI Listing
June 2005

Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.

Int J Radiat Oncol Biol Phys 2005 Apr;61(5):1364-70

Department of Oncology, Vanderbilt University School of Medicine and Veteran's Affairs Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2004.08.050DOI Listing
April 2005

Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?

Semin Oncol 2005 Feb;32(1):69-75

Department of Medicine, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009377540400464
Publisher Site
http://dx.doi.org/10.1053/j.seminoncol.2004.09.035DOI Listing
February 2005

A phase I study of 5-fluorouracil, leucovorin, and celecoxib in patients with incurable colorectal cancer.

Prostaglandins Other Lipid Mediat 2005 Jan;75(1-4):169-72

Oregon Health and Science University Cancer Institute, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prostaglandins.2004.10.004DOI Listing
January 2005

Targeted therapies in the treatment of colorectal cancer: what managed care needs to know.

J Manag Care Pharm 2004 Oct;10(5 Suppl B):S2-13; quiz S14-7

University of Pittsburgh School of Pharmacy, 3501 Terrace St., 1104 Salk Hall, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://www.amcp.org/data/jmcp/Octsupp20041.pdf
Web Search
October 2004